Results 111 to 120 of about 942,754 (267)
The algorithmic randomness of quantum measurements
This paper is a comment on the paper "Quantum Mechanics and Algorithmic Randomness" was written by Ulvi Yurtsever \cite{Yurtsever} and the briefly explanation of the algorithmic randomness of quantum measurements results. There are differences between the computability of probability sources, ( which means there is an algorithm that can define the way ...
openaire +2 more sources
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi +11 more
wiley +1 more source
Hierarchical Normalized Completely Random Measures for Robust Graphical Modeling. [PDF]
Cremaschi A +4 more
europepmc +1 more source
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park +6 more
wiley +1 more source
Sparse graphs using exchangeable random measures. [PDF]
Caron F, Fox EB.
europepmc +1 more source
Schnorr randomness for noncomputable measures
This paper explores a novel definition of Schnorr randomness for noncomputable measures. We say $x$ is uniformly Schnorr $μ$-random if $t(μ,x)
openaire +2 more sources
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
The publication was supported by the Spanish Ministry of Science and Innovation (reference PREP2022-000355, project MCINN23-PID2022-139886NB-I00), the Australian Research Council Discovery Project DP210100227 and the Principality of Asturias (BP21042).
Juan Baz +3 more
openaire +2 more sources

